LeMaitre Vascular, Inc. (LMAT) vs Anbio Biotechnology (NNNN)
LeMaitre Vascular, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. LeMaitre Vascular, Inc. is the larger, with a market value of $1.9B against $884.9M — 2.1× the size. Across the 9 metrics below, LeMaitre Vascular, Inc. leads on 6 and Anbio Biotechnology on 3.
Valuation
Profitability
| Metric | LMAT | NNNN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 72.90% | — | 54.62% |
| Operating margin | 29.46% | — | 1.64% |
| Net margin | 25.02% | — | 0.00% |
| Free cash flow margin | 28.13% | 0.00% | 1.61% |
| Return on equity | 16.77% | 0.00% | 0.00% |
| Return on assets | 10.78% | 0.00% | 0.00% |
| Return on invested capital | 22.67% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack